# Notice of Intent to Sole Source Biofire Global Fever Test Kits at U.S. Naval Hospital Okinawa, Japan

Canonical: https://abierto.us/opportunities/ht941024n0092

- Solicitation number: HT941024N0092
- Notice type: Award notice (first published as sources sought)
- Status: Awarded to Biofire Defense LLC for $38,820.00
- Department: Department of Defense
- Agency: Defense Health Agency (Dha)
- Contracting office: Defense Health Agency HCD West (HT9410)
- NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing
- Product or service code: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- Place of performance: JPN
- County: Salt Lake County (FIPS 49035). https://abierto.us/counties/salt-lake-county-ut-49035
- City: Salt Lake City. https://abierto.us/cities/salt-lake-city-ut-4967000
- First posted: July 1, 2024
- Last posted: July 12, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/3a963717a26e47c886e6adb7073b9728/view

## Description

The Defense Health Agency, Contracting Office - San Diego (HT9410), 7700 Arlington Blvd., Falls Church, VA 22042, has awarded a firm-fixed price (FFP), supply contract. The supplies provide BioFire Global Fever Special Pathogens Panel IVD, 6 Test (27 PG), and BioFire Shield Control Kit for GFSPP, 12 controls (2 PG). at U.S. Naval Hospital Okinawa, Japan. This sole source and firm-fixed price contract was awarded to Biofire Defense LLC on 11 July 202 for a one-time purchase base and no option pedriods.

Total contract value is $38,820.00. Biofire Defense LLC is the Original Equipment Manufacturer (OEM) of the BioFire Global Fever Special Pathogens Panel and BioFire Shield Control Kits. BioMérieux is the parent company.

However, BioFire Defense was created specifically to retain confidentiality of U.S. Government strategic assets under the Foreign Ownership Control and Influence (FOCI) mitigation agreement between the US Government, BioFire Defense (BFDF), BioMérieux, and all Affiliate companies owned by BioMérieux.

Because of this and its corresponding MOU, all US Department of Defense accounts fall solely under BioFire Defense LLC. Additionally, BioMérieux does not have authorization to sell the Global Fever Special Pathogens Test kits or Global Fever Special Pathogens SHIELD control kits. These kits are only available to be ordered through BioFire Defense. The second part of the Sole Source letter specifies that BioFire is the sole provider, and not BioMérieux.

## Award on USAspending

- Recipient: Biofire Defense LLC (UEI NHMDGM122546)
- Contract: HT941024P0187, purchase order
- Obligated: $38,820.00
- Competition: Not Competed Under SAP, 1 offers received
- Link: award number HT941024P0187 equals the contract number; same awarding office HT9410 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_HT941024P0187_9700_-NONE-_-NONE-/


## Publications

- July 1, 2024: Sources sought, due July 5, 2024 at 1:00 PM EDT. Notice 9dc1e6226c1b4885897a749f7fc4e834. https://sam.gov/workspace/contract/opp/9dc1e6226c1b4885897a749f7fc4e834/view
- July 12, 2024: Award notice. Notice 3a963717a26e47c886e6adb7073b9728. https://sam.gov/workspace/contract/opp/3a963717a26e47c886e6adb7073b9728/view

## Points of contact

- Adrian Nerida, adrian.m.nerida.civ@health.mil, 6197231493
- Pedro Reyes, pedro.a.reyes10.civ@health.mil, 2107925689

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/ht941024n0092.